02/14/2025
7:25 PM | FORWARD VENTURES V LP (Filed by)
Viracta Therapeutics, Inc. (Subject)
Viracta Therapeutics (Subject)
| Form SCHEDULE 13G | |
02/05/2025
4:00 PM | Viracta Therapeutics, Inc. (Filer)
Viracta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/24/2025
4:14 PM | Viracta Therapeutics, Inc. (Filer)
Viracta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/26/2024
3:39 PM | Viracta Therapeutics, Inc. (Filer)
Viracta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/29/2024
4:14 PM | Viracta Therapeutics, Inc. (Filer)
Viracta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/27/2024
3:06 PM | Pomerantz Roger (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
3:08 PM | ROYSTON IVOR (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2024
4:20 PM | Viracta Therapeutics, Inc. (Filer)
Viracta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
3:33 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Viracta Therapeutics, Inc. (Subject)
Viracta Therapeutics (Subject)
| Form SC 13G/A | |
11/13/2024
6:30 AM | Viracta Therapeutics, Inc. (Filer)
Viracta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2024
3:46 PM | Viracta Therapeutics, Inc. (Filer)
Viracta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for VIRX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Viracta Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
09/12/2024
5:10 PM | Pomerantz Roger (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
5:13 PM | ROYSTON IVOR (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
6:15 AM | Viracta Therapeutics, Inc. (Filer)
Viracta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/24/2024
6:47 PM | Murphy Samuel Lafayette (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
6:48 PM | Chung Jane (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
6:49 PM | Borellini Flavia (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
6:50 PM | ROYSTON IVOR (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
6:39 PM | Rubino Stephen (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
6:40 PM | Pomerantz Roger (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
6:43 PM | Barlow Jane F (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
6:44 PM | Simon Barry J. (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
6:46 PM | DARCY THOMAS E (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2024
3:46 PM | Viracta Therapeutics, Inc. (Filer)
Viracta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/29/2024
6:07 PM | ROYSTON IVOR (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
6:12 PM | Pomerantz Roger (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
4:04 PM | Viracta Therapeutics, Inc. (Filer)
Viracta Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/26/2024
3:15 PM | Viracta Therapeutics, Inc. (Filer)
Viracta Therapeutics (Filer)
| Form ARS | |
Buy VIRX Stock Free VIRX Stock Alerts